Dr. Evan Rosenbluth Joins RSC Team: Fertility Expert Expands Services

Dr. Evan Rosenbluth specializes in minimally-invasive fertility-sparing surgeries, non-invasive embryo health assessment, and award-winning endometriosis research impacting 6.3 million women. His expertise spans robotic procedures and disability-inclusive fertility treatments at RSC.

Key Takeaways

Minimally-Invasive Fertility-Sparing Surgery: Dr. Rosenbluth’s Expertise in Robotic Techniques

Dr. Rosenbluth performs robotic-assisted, fertility-preserving procedures that reduce recovery time and preserve reproductive potential. These surgeries are particularly beneficial for patients requiring complex interventions while maintaining future fertility options.

Non-Invasive Embryo Health Assessment: Advancing IVF Outcomes Without Biopsy

By developing biopsy-free methods for embryo selection, Dr. Rosenbluth improves IVF success rates while minimizing risks associated with traditional invasive testing. His techniques use metabolic and morphological biomarkers to identify viable embryos.

Endometriosis Research Breakthroughs: Addressing a Major Infertility Cause Affecting 6.3M Women

Dr. Rosenbluth’s award-winning work on endometriosis root causes provides new pathways for diagnosis and treatment. His research highlights the link between immune system dysfunction and endometriosis progression in reproductive-age women.

Disability-Inclusive Fertility Treatments: Expanding Access for Patients with Physical Challenges

Dr. Rosenbluth tailors fertility protocols to accommodate patients with disabilities, ensuring equitable access to reproductive care. This includes specialized approaches for mobility impairments and sensory processing needs during consultations and procedures.

Elective Single Embryo Transfer (eSET) Benefits: Reducing Multiples While Maintaining Success Rates

Through strategic eSET protocols, Dr. Rosenbluth achieves high pregnancy rates while minimizing risks of multiple births. This approach balances maternal health with reproductive goals, particularly for patients with optimal embryo quality.

Source: Read full article